Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof

US9605008B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Alexandros Vakalopoulos · Hilden, DE
• Alexey GROMOV · Erkrath, DE
• Markus Follmann
• Damian Brockschnieder · Haan, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Tobias Marquardt · Wuppertal, DE
• Adrian Tersteegen · Wuppertal, DE
• Frank Wunder · Wuppertal, DE
• Gorden Redlich · Bochum, DE
• Dieter Lang · Velbert, DE
• Volkhart Min-Jian Li · Velbert, DE

Key dates

• Filing date: Jul 8, 2014
• Grant date: Mar 28, 2017
• Expiry date: Jul 8, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel benzyl-1H-pyrazolo[3,4-b]pyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.